Test Code Billings Clinic: 8142 Mayo: CA153 Cancer Antigen 15-3 (CA 15-3), Serum
Additional Codes
Ordering Mnemonic |
---|
MayoAccess: BCL338 |
Reporting Name
Cancer Ag 15-3, (CA 15-3), SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Managing breast cancer patients when used in conjunction with clinical information and other diagnostic procedures
Serial testing to assist in early detection of disease recurrence in previously treated stage II and III breast cancer patients
Monitoring response to therapy in metastatic breast cancer patients
This test is not useful as a cancer screening test.
Method Name
Electrochemiluminescence Immunoassay (ECLIA)
Specimen Required
Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).
Supplies: Sarstedt 5 mL Aliquot Tube (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Type
SerumSpecimen Minimum Volume
0.75 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 90 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Reference Values
Males: <30 U/mL (use not defined)
Females: <30 U/mL
Interpretation
Increasing and decreasing values show correlation with disease progression and regression, respectively.(1) Increasing cancer antigen 15-3 (CA 15-3) assay values in patients at risk for breast cancer recurrence after primary therapy may be indicative of recurrent disease before it can be detected clinically (2,3) and may be used as an indication that additional tests or procedures should be performed.
Day(s) Performed
Monday through Saturday
Report Available
1 to 3 daysTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86300
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CA153 | Cancer Ag 15-3, (CA 15-3), S | 83083-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CA153 | Cancer Ag 15-3, (CA 15-3), S | 83083-6 |
Forms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.